Transition Therapeutics Inc (NASDAQ:TTHI)

2.17
Delayed Data
As of Jul 02
 +0.06 / +2.84%
Today’s Change
2.02
Today|||52-Week Range
9.30
-68.26%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Transition Therapeutics Inc have a median target of 4.66, with a high estimate of 10.00 and a low estimate of 2.62. The median estimate represents a +114.83% increase from the last price of 2.17.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Transition Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$0.00
Reporting Date
Sep 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -64.13%
 
 
 
 
 
 
Growthannually -59.47%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account